The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Why a well-planned supply strategy is essential for clinical success: Expert insight series
Go inside Accelerator™ Drug Development to understand the importance of a well-planned supply strategy—plus how early alignment and cross-team coordination can help reduce handoffs and avoid delays in clinical development.
Successful clinical trials don't just require a promising drug—they also require a well-planned clinical supply strategy. Engaging cross-functional teams early allows sponsors to align manufacturing, forecasting, packaging, labeling, and distribution decisions long before the first patient is enrolled. This approach helps identify potential risks, supports smarter decision-making, and creates a more reliable path to successful study execution.
An integrated model also helps overcome one of the most common challenges in clinical development: coordinating multiple vendors. In this video, Patty Pisano, Senior Manager of Global Client Management at Thermo Fisher Scientific, explores common pitfalls in the clinical supply landscape and explains how working across separate providers can create communication gaps and misaligned timelines, leading to unnecessary delays and operational complexity.
An end-to-end, one-team approach streamlines clinical trial operations
Ultimately, an end-to-end clinical supply strategy allows sponsors to spend less time managing operational details and more time focusing on what matters most—advancing their clinical programs. Bringing clinical supply, manufacturing, logistics, regulatory expertise, and clinical operations together under one organization creates a more connected process, reducing handoffs and enabling teams to work more effectively toward shared goals.
Key reasons why a connected clinical supply strategy is essential for successful trials:
- Early collaboration improves forecasting, reduces risk, and supports more informed decision-making
- Proactive planning helps identify challenges, including QP release and import/export requirements
- Connected teams minimize communication gaps and help keep clinical trial timelines on track
- End-to-end operational support allows biopharma developers to focus on advancing their science
Expert:
Patty Pisano, Senior Manager, Global Client Management
Patty Pisano is Senior Manager, Global Client Management at Thermo Fisher Scientific, supporting customers with clinical supply planning and strategy. Her work brings together manufacturing and clinical considerations to support forecasting, packaging, labeling, and distribution needs for clinical trials. She emphasizes early planning and collaboration to help customers anticipate supply requirements and navigate operational and regulatory complexities.
This is part of a larger series, “Expert Perspective: Inside Accelerator™ Drug Development.” Watch the full video featuring seven industry-leading, cross-functional experts here.